Baxter International Inc.

BAX

NYSE

Healthcare

Medical - Instruments & Supplies

Deerfield, IL, US38,000 employeesbaxter.com

$16.69

-0.09(-0.5%)

52W $15.80 – $31.88

AI-generated from 10-K FY2025 filed Feb 11, 2026

Baxter International Inc.

Revenue breakdown: Infusion Therapies And Technologies (38.4%), Care And Connectivity Solutions (17.4%), Injectables And Anesthesia (12.8%).

$8.6BMkt Cap

$11.3BRev TTM

-$958MNI TTM

-8.9xP/E TTM

Latest Earnings

10-K

FY FY2025Feb 11, 2026

Baxter International Inc. (BAX) reported FY 2025 net sales of $11.24B, with gross margin of $3.38B after $7.87B cost of sales. Operating loss reached -$308.0M, driven by $2.89B SG&A, $518.0M R&D, $485.0M goodwill impairments, and $206.0M other operating expenses. Interest expense net was -$238.0M, leading to pre-tax loss from continuing operations of -$505.0M. Despite a $395.0M tax expense, continuing operations...

Read full analysis View SEC Filing

What Changed Recently

Regulation FDMar 18, 2026

, including Exhibit 99.1 to this Current Report on Form 8-K, shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as ame

View filing →

Management ChangeMar 15, 2026

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Transition of

View filing →

Management Change+3 MoreFeb 11, 2026

of Form 8-K, including Exhibit 99.1, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as am

View filing →

View all recent events →

Fundamentals

How The Business Makes Money

Revenue by Segment

Infusion Therapies And Technologies38.4%($24.3B)

Care And Connectivity Solutions17.4%($11.1B)

Injectables And Anesthesia12.8%($8.1B)

Front Line Care11.1%($7.0B)

Other20.3%($12.9B)

Revenue by Geography

US47.9%($53.0B)

Non Us39%($43.2B)

Western Europe Canada Japan Australia And New Zealand9.4%($10.4B)

Eastern Europe Middle East Africa Latin America Asia3.7%($4.1B)

Peer Companies

Company	Price	Change	Market Cap	P/E
MDGLMadrigal Pharmaceuticals,...	$544.43	+2.75%	$12.5B	-34.8
DVADaVita Inc.	$145.64	-3.13%	$9.7B	17.5
MASIMasimo Corporation	$178.57	+0.32%	$9.6B	-63.1
QGENQiagen N.V.	$41.05	+1.65%	$8.5B	19.3
ATRAptarGroup, Inc.	$126.21	-0.43%	$8.1B	20.6
BIOBio-Rad Laboratories, Inc...	$280.03	+0.60%	$7.6B	9.4
RGENRepligen Corporation	$117.83	-0.41%	$6.6B	134.5
AVTRAvantor, Inc.	$7.88	+1.48%	$5.4B	-9.7

Company Profile

CIK0000010456

ISINUS0718131099

CUSIP071813109

Phone224 948 2000

AddressOne Baxter Parkway, Deerfield, IL, 60015, US

SEC EDGAR